Manufacturing facilities involved in Taiwan’s drug registration must comply with Good Manufacturing Practice (GMP) standards. This includes maintaining stringent quality control systems, ensuring proper equipment and facility hygiene, and documenting production processes. The TFDA inspects these facilities to verify compliance, and non-compliance can result in registration delays or rejections.
